Health

Results: 1117-1128 of 9513

SciBase publishes the Annual report for 2025

Bioretec Ltd - Manager's transactions - Paavola

PCI Pharma Services announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities.

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development

vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

Business Wire associated0

Peloton’s World-Class Content to Fuel Spotify’s New Fitness Category Globally

Business Wire logo

Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients

The EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

Photo credit: Jos Schmid, Photographer

vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

PR Newswire associated0

CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026

GlobeNewswire associated0

Every minute counts: EAACI calls for urgent action to make schools safe for children at risk of anaphylaxis

PR Newswire associated0

Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen